At Linlithgow Family Office, we specialise in partnering with high-impact ventures at the intersection of medical innovation and translational research.
We have a particular interest in
- Late-stage clinical trials with clear inflection points
- Repurposed and off-patent drugs targeting underserved indications
- Breakthroughs in diagnostics, therapeutics, and patient care delivery
- MedTech and digital health platforms with scalable, regulatory-ready models
Our approach is guided by deep sectoral insight, a rigorous due diligence process, and long-term partnerships with principal investigators, CROs, and global sponsors.
